RadNet, a major U.S. diagnostic imaging provider, has acquired See-Mode Technologies, an innovator in AI-powered ultrasound diagnostics for breast and thyroid cancers12345.
See-Mode’s FDA-approved ultrasound AI solutions automatically detect and characterize thyroid nodules and breast lesions, enhancing diagnostic accuracy and standardizing reporting234.
The AI technology has been integrated into RadNet’s DeepHealth platform, demonstrating up to a 30% reduction in scan times, thus improving workflow efficiency at RadNet’s imaging centers345.
RadNet performs approximately 250,000 thyroid ultrasounds annually, and the new technology may allow some of these to receive additional reimbursement due to an existing reimbursement code4.
The acquisition positions RadNet at the forefront of AI-driven ultrasound innovation, addressing the high volume and complexity of thyroid and breast cancer diagnostics, particularly important for women's health234.
This move follows RadNet’s strategy to expand its AI portfolio, coming less than two months after its planned acquisition of another breast imaging AI vendor, iCAD3.
Sources:
1. https://www.globenewswire.com/news-release/2025/06/04/3093960/0/en/RadNet-Inc-Acquires-See-Mode-Technologies-for-Innovation-in-AI-Powered-Ultrasound-Diagnostics.html
2. https://www.radnet.com/about-radnet/news/radnet-inc-acquires-see-mode-technologies-for-innovation-in-ai-powered-ultrasound-diagnostics
3. https://radiologybusiness.com/topics/artificial-intelligence/radnet-enters-ultrasound-ai-acquiring-imaging-vendor-see-mode-technologies
4. https://www.auntminnie.com/imaging-informatics/artificial-intelligence/news/15747786/radnet-inc-radnet-buys-ultrasound-ai-developer-seemode-technologies
5. https://www.investing.com/news/company-news/radnet-acquires-ai-ultrasound-innovator-seemode-93CH-4081516